
BranchLab
BranchLab is a healthcare AI platform helping pharma companies commercialize therapies with privacy-safe data.
- Company
- New York, NY, USUnited States

BranchLab is a healthcare AI platform helping pharma companies commercialize therapies with privacy-safe data.
branchlab.comCrawled Oct 14, 2026
Turn complex healthcare data into commercial intelligence that improves audience strategy, commercial performance, and real-world health outcomes.
BranchLab introduces **Privacy Updates for Marketing Activation**, a tool offering state-by-state legal guidance on healthcare privacy regulations. The resource helps marketers navigate evolving compliance requirements amid shifting healthcare privacy laws. It consolidates fragmented legal frameworks into actionable insights for activation campaigns.
Aug 2026PR NewswireNews article
BranchLab secures **$26 million in Series A funding** led by McKesson Ventures to advance its AI-driven pharma commercialization tools. The company emphasizes **privacy-first AI** as a core differentiator in marketing for pharmaceutical products. This investment supports scaling operations and expanding capabilities in the healthcare marketing sector.
May 2026AIPressRoomNews article
BranchLab, an AI platform for pharmaceutical commercialization, raises a $26 million Series A led by McKesson Ventures. FCA Venture Partners, Sanofi Ventures, and AIX Ventures also participate. The company describes its technology as privacy-first AI for transforming how pharmaceutical companies commercialize therapies.
May 2026TechStartupsNews article
BranchLab secures $26 million in Series A funding to develop an AI-driven platform for pharmaceutical commercialization. The round is led by McKesson Ventures, supporting the company’s mission to integrate artificial intelligence into drug launch and market access strategies. The platform aims to optimize decision-making for biopharma companies through data-driven insights.
May 2026McKesson VenturesNews article